Sign in
4

Changes in Ownership

IOVANCE BIOTHERAPEUTICS, INC. Filed Acc 0001104659-23-109940

Chief Medical Officer gave up 1,395 shares (to pay taxes)

  • Chief Medical Officer acquired 2,813 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
GRAF FINCKENSTEIN FRIEDRICH Chief Medical Officer 2023-10-16 Option exercise +2,813 33,766 D: show line 1 in the form
GRAF FINCKENSTEIN FRIEDRICH Chief Medical Officer 2023-10-16 Shares withheld for taxes −1,395 $3.57 $4,980 32,371 D: show line 2 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
GRAF FINCKENSTEIN FRIEDRICH Chief Medical Officer 2023-10-16 Option exercise · Restricted Stock Units −2,813 14,064 D: show line 3 in the form
Loading xslF345X05/tm2328751-1_4seq1.xml…